Reports

Annual Drug Utilization Reports

  • MAPS Drug Utilization Reports offer data regarding controlled substance prescriptions dispensed in Michigan. In 2018, the number of opioid prescriptions dispensed decreased by 22.0 percent since 2015 while the overall number of schedules 2-5 controlled substance prescriptions dispensed decreased by 17.9 percent during that same timespan.

  •  

    Total CS prescriptions dispensed

    % change from previous year

    2007

    17,007,858

     

    2008

    17,400,640

    2.31%

    2009

    17,876,684

    2.74%

    2010

    18,954,172

    6.03%

    2011

    19,763,680

    4.27%

    2012

    20,991,020

    6.21%

    2013

    20,728,216

    -1.25%

    2014

    20,904,764

    0.85%

    2015

    21,472,326

    2.71%

    2016

    21,092,674

    -1.77%

    2017 19,943,203 -5.45%

    2018

    17,642,901

    -11.53%

  • Select the years below to access individual drug utilization reports.

State Opioid Assessment

  • A new statewide assessment has identified trends that will assist government agencies, lawmakers and local community leaders tailor laws, target resources, and design innovative programs to best address the opioid epidemic in Michigan.

    The assessment overlays three years (2013-2015) of well-documented cases of unintentional overdose death with five years (2012-2017) of prescription records in the Michigan Automated Prescription System (MAPS). In total, more than 7.5 million patients receiving 103.2 million prescriptions over the last five years were linked to 5,261 overdose deaths.

    The assessment provides valuable information about patterns of opioid usage in Michigan by detailing patient-level and aggregate trends of controlled-substance prescriptions and overdose deaths within the state.


    READ THE FULL ASSESSMENT

NarxCare Effectiveness Study

  • Narxcare Effectiveness Study Introduction

    A new study, the Michigan AWARxE/NarxCare Implementation Evaluation, is the nation’s first study evaluating the effectiveness of NarxCare. Appriss’s Michigan Implementation and Evaluation analyzes NarxCare risk scores and shows a decline in patients with a high potential to abuse prescription drugs.


    READ THE FULL ASSESSMENT

MAPS Resources

Contact MAPS

MAPS Integration

  • MAPS Partners

    The State of Michigan is covering the full cost of integration of MAPS into the clinical workflow of health systems, physician groups and pharmacies until August 31, 2019. Learn how to start the integration process.

MAPS Legislation

  • MAP Legislation Info

    If your question(s) pertain to the new opioid legislation, we encourage you to review the recently-released FAQs. Additional questions or concerns can be addressed by contacting MAPS.

  • MAPS Partners

    MDHHS

    Find Help, Hope & Resources for Opioids

    MSP Angel Program

    Find Opioid Addiction Resources

  • Facebook Icon
    Twitter Icon
    YouTube Icon
    Instagram Icon